Delivery Order SPE2DB20D7059-SPE2DB22FPSZ9
Award Date 8/17/22
Potential Completion Date 8/18/22
Potential Value $1.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4560843660 - Methylergonovine 0.2 mg/ml vials, with a ceiling value of $1,653.27 and a performance period through May 8, 2023. The contract is a firm fixed-price agreement, with no set-aside designation indicated. Amerisourcebergen is the prime contractor, and there is no...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565749596 - Methylergonovine 0.2 mg/ml vials. The contract is a Delivery Order with a Firm Fixed Price of $2,127.78 and an Ultimate Completion Date of September 11, 2024. The contract is not a set-aside. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. The contract is part of a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,042.84, is for the delivery of methylergonovine 0.2 mg/ml vials, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price pricing type and a completion date of October 18, 2024. This contract is not designated as a set-aside and is part of a larger Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,147.50 firm fixed-price delivery order is for the supply of METHYLERGONOVINE 0.2 MG/ML VLML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2022 and was awarded on September 29, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $2,873.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4560862324 - Methylergonovine 0.2 mg/ml vials, with a performance period ending on May 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency awarded a $13,917.06 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Methylergonovine 0.2 mg/mL vials. This firm fixed-price contract, with an ultimate completion date of September 25, 2025, was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,052.10 delivery order to AmerisourceBergen Drug Corp for the supply of Methylergonovine 0.2 mg/ml in ampule form, with a completion date of January 12, 2026. The contract was competitively awarded on January 9, 2026, with no set-aside designation, utilizing firm fixed-price pricing. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this order, with the company's parent entity being Cencora, Inc....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,156.84 firm-fixed-price delivery order covers the supply of 4564904974 - METHYLERGONOVINE 0.2 MG/ML VLML, with a period of performance through June 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,596.71, is for the delivery of Methylergonovine 0.2 mg tablets. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,393.28, is a Firm Fixed Price Delivery Order for the supply of 4567804573 METHYLERGONOVINE 0.2 MG/ML VLML. The contract has an ultimate completion date of April 7, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...